China NT Pharma Group Company Limited
Research China NT Pharma Group Company Limited (1011.HK) on Bullrun: market cap HKD 538.97M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1011.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyHKD
- Market capHKD 538.97M
- Financial periodFY2025
- RevenueCNY 24.16M
- Revenue growth-36.4%
- Net income-CNY 26.04M
- Free cash flow-CNY 5.55M
- Gross margin39.8%
Valuation Snapshot
latest market cap is HKD 538.97M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 24.16M | -CNY 26.04M | -CNY 5.55M | 39.8% | -0.04 | CNY 7.22M | CNY 316.70M | -CNY 273.62M |
| FY2024 | CNY 37.96M | -CNY 53.36M | -CNY 9.24M | 13.9% | -0.2 | CNY 9.62M | CNY 375.95M | -CNY 399.11M |
| FY2023 | CNY 7.37M | -CNY 143.59M | CNY 37.58M | 100.0% | -0.73 | CNY 1.52M | CNY 344.94M | -CNY 339.57M |
| FY2022 | CNY 0 | -CNY 66.41M | CNY 31.72M | n/a | -0.35 | CNY 1.92M | CNY 826.45M | -CNY 241.66M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 538.97M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About China NT Pharma Group Company Limited
China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People's Republic of China. It operates through Agency Services and Healthcare Related Services segments. The company acts as agent for clients to sell proprietary pharmaceutical products and artificial intelligence bone density testings to external customers.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is China NT Pharma Group Company Limited's market cap?
China NT Pharma Group Company Limited's market capitalization is HKD 538.97M.
What does China NT Pharma Group Company Limited do?
China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People's Republic of China. It operates through Agency Services and Healthcare Related Services segments. The company acts as agent for clients to sell proprietary pharmaceutical products and artificial intelligence bone density testings to external customers. It also provides healthcare related research and promotion services in relation to bone health knowledge.